Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 1/20 | 0.38 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.32 |
| ▸ | ITGAV | P06756 | 1/20 | 0.32 |
| ▸ | PPARG | P37231 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16093430 | 0.95 | FAAH (0.34) | FAAHPPARG | |
| SCHEMBL12809270 | 0.91 | FAAH (0.34) | FAAHPPARG | |
| SCHEMBL13892164 | 0.90 | FAAH (0.38) | FAAH | |
| SCHEMBL13226753 | 0.90 | ALDH1A1 (0.32) | FAAHPPARG | |
| SCHEMBL12673964 | 0.90 | PPARG (0.36) | FAAHITGB3ITGAVPPARG | |
| SCHEMBL1688196 | 0.90 | PPARG (0.36) | FAAHITGB3ITGAVPPARG | |
| SCHEMBL16093010 | 0.89 | CASP2 (0.40) | FAAH | |
| SCHEMBL13113625 | 0.89 | CASP2 (0.40) | FAAH | |
| SCHEMBL12641022 | 0.88 | PPARG (0.30) | PPARG | |
| SCHEMBL13694066 | 0.88 | PPARG (0.30) | PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9067977-B2 | Peptides derivatized with A-B-C-D- and their therapeutical use | NOVO NORDISK A/S (DK) | 2015-06-30 | — | — | US | disclosed |
| US-9061067-B2 | Polypeptide protracting tags | NOVO NORDISK A/S (DK) | 2015-06-23 | — | — | US | disclosed |
| US-8841249-B2 | Growth hormones with prolonged in-vivo efficacy | NOVO NORDISK A/S (DK) | 2014-09-23 | — | — | US | disclosed |
| US-20140011732-A1 | Peptides Derivatized with A-B-C-D- and their Therapeutical Use | NOVO NORDISK A/S (DK) | 2014-01-09 | — | — | US | disclosed |
| US-20120088716-A1 | Polypeptide Protracting Tags | NOVO NORDISK A/S (DK) | 2012-04-12 | — | — | US | disclosed |
| US-20090111730-A1 | Polypeptide protracting tags | NOVO NORDISK A/S (DK) | 2009-04-30 | — | — | US | disclosed |
| US-20090111730-A1 | Polypeptide protracting tags | NOVO NORDISK A/S (DK) | 2009-04-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140011732-A1 | Peptides Derivatized with A-B-C-D- and their Therapeutical Use | GLP1R, IAPP, GIPR | FAAH 1208/4885ITGB3 2129/4885ITGAV 2588/4885 |
| US-20120088716-A1 | Polypeptide Protracting Tags | VIP, FGB, NPPA | FAAH 2944/4885ITGB3 672/4885ITGAV 407/4885 |
| US-20090111730-A1 | Polypeptide protracting tags | LNPEP, FGB, ENPEP | FAAH 2903/4885ITGB3 630/4885ITGAV 412/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.